Lee Ainslie - Maverick Capital
Holding/activity history for Ultragenyx Pharmaceutical In (RARE)
← All RARE superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2021 Q4 | 0 | 0.00 | Sell 100.00% | <0.01 | $72.89–89.72 · VW $81.74i | SEC | |
| 2021 Q3 | 5,861 | <0.01 | Reduce 42.38% | <0.01 | $76.78–104.38 · VW $89.28i | $529,000 | SEC |
| 2021 Q2 | 10,172 | 0.01 | Reduce 8.96% | <0.01 | $91.93–120.00 · VW $102.67i | $970,000 | SEC |
| 2021 Q1 | 11,173 | 0.01 | Buy | 0.01 | $102.90–175.00 · VW $135.82i | $1,272,000 | SEC |